Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in JapanPR Newswire
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic DermatitisPR Newswire
NOTICE OF THE TWENTY-FIFTH ANNUAL GENERAL MEETING OF SHAREHOLDERSPR Newswire
Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in JapanPR Newswire
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer at 2024 ASCO Annual MeetingPR Newswire
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer and Gastric CancerPR Newswire
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic DermatitisPR Newswire
Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer ImagingPR Newswire
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature MedicineGlobeNewswire
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular LymphomaBusiness Wire
RNS announcements are delayed by up to an hour.
...